PAN L CAP

Distributor inventory | Capsule

Gastroesophageal reflux disease (GERD), acidity/heartburn, gastritis, functional dyspepsia, nausea/bloating associated with delayed gastric emptying

Pantoprazole is a proton pump inhibitor that reduces stomach acid by blocking the H+/K+ ATPase pump in gastric parietal cells. Levosulpiride is a prokinetic (D2 receptor antagonist) that improves gastric motility and helps relieve nausea, fullness and reflux symptoms.

Capsule: take as prescribed, usually 1 capsule once daily 30 minutes before food (preferably before breakfast). Swallow whole; do not crush or chew (SR/EC formulation).

Headache, diarrhoea, abdominal pain, nausea, constipation, dizziness, dry mouth, sleepiness, restlessness, increased prolactin (breast tenderness/galactorrhoea), menstrual irregularities

Use with caution in liver impairment; prolonged PPI use may increase risk of vitamin B12 deficiency, low magnesium, fractures and infections. Levosulpiride may cause extrapyramidal symptoms, drowsiness and raised prolactin; avoid in patients with prolactin-dependent tumors, pheochromocytoma, epilepsy, Parkinsonism or history of movement disorders. Seek medical advice if alarm symptoms occur (weight loss, persistent vomiting, GI bleeding, difficulty swallowing).

Anticoagulants (e.g., warfarin—monitor INR), drugs requiring acidic pH for absorption (ketoconazole, itraconazole, atazanavir), digoxin (risk with low magnesium), methotrexate (high dose), antipsychotics/other dopamine antagonists (additive extrapyramidal effects), levodopa/dopamine agonists (reduced effect), QT-prolonging drugs (caution)